Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Unregulated inflammation shortens human functional longevity.

¹University of Texas Health Science Center at Houston, Department of Neurology, 77225, USA. Staley.a.brod@uth.tmc.edu

Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]

|December 29, 2000

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Variable results after rituximab in neuromyelitis optica.

Journal of the neurological sciences·2012

Same author

Ingested IFN-alpha preserves residual beta cell function in type 1 diabetes.

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research·2002

Same author

Ingested IFN-alpha: results of a pilot study in relapsing-remitting MS.

Neurology·2001

Same author

Ingested interferon-alpha prevents allograft islet transplant rejection.

Transplantation·2000

Same author

Adoptive transfer from interferon-alpha-fed mice is associated with inhibition of active experimental autoimmune encephalomyelitis by decreasing recipient tumor necrosis factor-alpha secretion.

Journal of immunotherapy (Hagerstown, Md. : 1997)·2000

Same author

Combination therapy with glatiramer acetate (copolymer-1) and a type I interferon (IFN-alpha) does not improve experimental autoimmune encephalomyelitis.

Annals of neurology·2000

Systemic inflammation drives autoimmune diseases, Alzheimer's disease, and atherosclerosis. Unregulated immune responses to self or foreign elements critically impact neurological and cardiovascular health, shortening human lifespan.

Area of Science:

Immunology
Pathology
Neurology

Background:

Systemic inflammation, driven by pro-inflammatory cytokines, is a key human response to external threats.
Three major human ailments—autoimmunity, Alzheimer's disease (AD), and atherosclerosis—are initiated or exacerbated by systemic inflammation.

Purpose of the Study:

To elucidate the critical role of unregulated systemic inflammation in common neurological and cardiovascular diseases.
To highlight the impact of systemic inflammation on autoimmunity, Alzheimer's disease, and atherosclerosis.

Main Methods:

Review of existing literature on systemic inflammation and its role in disease pathogenesis.
Analysis of immune system responses in autoimmunity, Alzheimer's disease (amyloid-beta protein), and atherosclerosis (cholesterol deposition).

Related Experiment Videos

Main Results:

Autoimmunity involves hyperimmunity and T-cell exhaustion, linked to cytokine dysregulation.
Alzheimer's disease pathogenesis involves amyloid-beta protein triggering a local brain inflammatory response, driven by systemic immune processes.
Atherosclerosis features inflammatory plaques with activated immune cells, potentially secondary to pro-inflammatory cytokines.

Conclusions:

Unregulated systemic inflammation is a critical factor in the pathogenesis of autoimmunity, Alzheimer's disease, and atherosclerosis.
These inflammatory processes contribute to neurological and cardiovascular diseases, significantly impacting human longevity.